David T. Rodgers

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

David T. Rodgers, Magdalena Mazagova, Eric Hampton et al. · Proceedings of the National Academy of Sciences · 2016 · 405 citations · Full text

Life Sciences, Immunology, Oncology +17

Versatile strategy for controlling the specificity and activity of engineered T cells

S. Y. Jennifer, Ji Young Kim, Stephanie A. Kazane et al. · Proceedings of the National Academy of Sciences · 2016 · 276 citations · Full text

Life Sciences, Immunology, Oncology +17

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma

Deepak B. Thimiri Govinda Raj, Ming-Hsin Yang, David T. Rodgers et al. · Gut · 2018 · 149 citations · Full text

Life Sciences, Immunology, Oncology +17

Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer

Yu Cao, David T. Rodgers, Juanjuan Du et al. · Angewandte Chemie International Edition · 2016 · 117 citations

Life Sciences, Immunology, Oncology +17

Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the <i>Acanthocheilonema viteae</i> Product ES-62 Prevents Development of Collagen-Induced Arthritis

Lamyaa Al‐Riyami, Miguel A. Pineda, Justyna Rzepecka et al. · Journal of Medicinal Chemistry · 2013 · 92 citations

Veterinary Medicine, Immunology, Pharmacology +17